← Every applicant
I3 Pharms FDA Approvals
5 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| EVEROLIMUSNew drugJun 30, 2026TABLET, ORAL |
| PALIPERIDONENew drugMay 7, 2026TABLET, EXTENDED RELEASE, ORAL |
| RIFABUTINNew drugMar 19, 2026CAPSULE, ORAL |
| ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDENew drugJan 17, 2024TABLET, ORAL |
| RANOLAZINENew drugApr 27, 2022TABLET, EXTENDED RELEASE, ORAL |